Biostem Technologies New BSEM

$2.09 +0.05 (2.45%)

Valuation

Market cap
39,024,000
Revenue TTM
$47,480,000
Net income TTM
$-6,580,000
PE ratio
0.00
Forward PE
—
Profit margin
-13.86%
Debt to equity
0.00

Trading

Volume
33,400
Avg volume
147,444
Day's range
$2.03 – $2.10
Shares out
18,672,000
Stochastic %K
23%
Beta
0.17
Analysts
Sell
Price target
$7.00

Price

Company profile

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje...

Show more

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.

Industry
Biotechnology
Sector
Healthcare
Phone
954 380 8342
Website
https://biostemtechnologies.com
Address
4901 Northwest 17th Way, Suite 606, Fort Lauderdale, United States

Latest news

Stocktwits

idkmikes57 Oct 2, 10:49 PM
$BSEM burned.
0 replies
MarianoItaliano Oct 2, 5:54 PM
$BSEM this 3M$ in private placement cost them like 15M$ in market cap lol brutal
0 replies
ZTRADEZ_LLC Sep 18, 4:06 PM
$BSEM What an update
0 replies
MingChoo Sep 13, 12:45 PM
$BSEM Looking good)
0 replies
BloomBoom Sep 8, 3:19 AM
$BSEM 👀🤫
0 replies
MRSUNNY Sep 4, 3:08 PM
$BSEM
0 replies
Mimarcano Aug 31, 3:53 PM
$BSEM 👀
0 replies
ZTRADEZ_LLC Aug 26, 5:38 PM
ON MY RADAR: NASDAQ: $BSEM *Sponsored BioStem Technologies expanded its surgical and wound-care business through the acquisition of BioTissue's Neox® and Clarix® products. Why it has my attention: • ~$29M in 2025 sales from the acquired assets • Expanded hospital and surgical wound-care presence • Broader national commercial footprint • ~$26B estimated underserved U.S. soft-tissue opportunity The Catalyst I Am Watching: Catalyze received FDA 510(k) clearance in June 2026, with a potential commercial launch in Q4 2026 and further regulatory expansion beginning in 2027. Communicated Disclaimer https://ztradez.net/communicated-disclaimer3/
0 replies